DEXCOM, INC. Repayments of Convertible Debt
DEXCOM, INC. (DXCM) reported Repayments of Convertible Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-02-12
- DEXCOM, INC. repayments of convertible debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- DEXCOM, INC. repayments of convertible debt for the quarter ending 2023-12-31 was $136.80M.
- DEXCOM, INC. repayments of convertible debt for the quarter ending 2022-12-31 was $0.00.
- DEXCOM, INC. repayments of convertible debt for fiscal 2025 was $0.00.
- DEXCOM, INC. repayments of convertible debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- DEXCOM, INC. repayments of convertible debt for fiscal 2023 was $787.30M.
- DEXCOM, INC. repayments of convertible debt for fiscal 2022 was $0.00.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-12 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 10-K · filed 2026-02-12 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-24 | ||
| 2023-12-31 | $136.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $787.30M 10-K · filed 2026-02-12 | |
| 2023-09-30 | $650.50M 10-Q · filed 2024-10-24 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-26 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |